Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It must be close to Letter to the Shareholders time. eom
Reply New Message
Prev Message Back To Forum Threaded View Next Message

My uneducated guess is, the Conference Call replaces the Shareholder Letter, at least this month and maybe until the next 10K...but a good question I can ask PTSC's IR.

GLTY

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply